A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors
- First Posted Date
- 2022-05-31
- Last Posted Date
- 2023-07-20
- Lead Sponsor
- SUNHO（China）BioPharmaceutical CO., Ltd.
- Target Recruit Count
- 140
- Registration Number
- NCT05396391
- Locations
- 🇨🇳
Shanghai East Hospital, Shanghai, Shanghai, China
Clinical Trial of IBC0966 in Patients With Advanced Malignant Tumors
Phase 1
Recruiting
- Conditions
- Advanced Malignant Tumors
- Interventions
- Biological: IBC0966
- First Posted Date
- 2021-07-28
- Last Posted Date
- 2023-03-10
- Lead Sponsor
- SUNHO（China）BioPharmaceutical CO., Ltd.
- Target Recruit Count
- 228
- Registration Number
- NCT04980690
- Locations
- 🇨🇳
The Affiliated Tumor Hospital of Harbin Medical University, Harbin, Heilongjiang, China
Clinical Study of IAH0968 in Patients With HER2-positive Advanced Solid Tumors
Phase 1
Recruiting
- Conditions
- Advanced Solid Tumor
- Interventions
- First Posted Date
- 2021-06-22
- Last Posted Date
- 2024-02-20
- Lead Sponsor
- SUNHO（China）BioPharmaceutical CO., Ltd.
- Target Recruit Count
- 97
- Registration Number
- NCT04934514
- Locations
- 🇨🇳
The First Hospital of China Medical University, Shenyang, Liaoning, China
© Copyright 2025. All Rights Reserved by MedPath